Cette traduction est en cours de préparation. En attendant, nous affichons temporairement la version originale en anglais.
Entreprise · 23/10/20021 min de lecture
Agency Information Collection Activities; Announcement of OMB Approval; Postmarketing Adverse Drug Experience Reporting
Traduction automatique locale · Langue originale de la source
Résumé
The Food and Drug Administration (FDA) is announcing that a collection of information entitled "Postmarketing Adverse Drug Experience Reporting" has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995 (the PRA).
Langue originale de la source: Federal Register — Food and Drug AdministrationOuvrir le communiqué original →